STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Update

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the recipient of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 3,700 shares, a growth of 208.3% from the September 30th total of 1,200 shares. Currently, 0.2% of the company’s shares are short sold. Based on an average trading volume of 10,500 shares, the days-to-cover ratio is presently 0.4 days.

STRATA Skin Sciences Price Performance

Shares of NASDAQ SSKN remained flat at $3.12 during midday trading on Friday. The stock had a trading volume of 1,922 shares, compared to its average volume of 11,838. The company has a quick ratio of 0.92, a current ratio of 1.14 and a debt-to-equity ratio of 1.59. STRATA Skin Sciences has a fifty-two week low of $2.51 and a fifty-two week high of $6.96. The company has a market cap of $13.01 million, a P/E ratio of -1.28 and a beta of 1.35. The business has a fifty day moving average of $3.02 and a two-hundred day moving average of $3.44.

STRATA Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share for the quarter. STRATA Skin Sciences had a negative net margin of 25.40% and a negative return on equity of 50.45%. The business had revenue of $8.44 million for the quarter. On average, research analysts forecast that STRATA Skin Sciences will post -1 EPS for the current year.

Institutional Trading of STRATA Skin Sciences

A hedge fund recently raised its stake in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV grew its position in shares of STRATA Skin Sciences, Inc. (NASDAQ:SSKN) by 289.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 67,000 shares of the medical device company’s stock after purchasing an additional 49,800 shares during the period. Azzad Asset Management Inc. ADV owned approximately 0.19% of STRATA Skin Sciences worth $25,000 as of its most recent SEC filing. Institutional investors and hedge funds own 32.43% of the company’s stock.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.